Comparison of the bioMérieux NucliSENS EasyQ HIV-1 v2.0-HIV-1 RNA quantification assay versus Abbott RealTime HIV-1 and Roche Cobas TaqMan HIV-1 v2.0 on current epidemic HIV-1 variants

Journal of Clinical Virology

Volumn 71, Issue , 2015, Pages 76-81

  Mourez, Thomas ^a,b,c   Delaugerre, Constance ^d,e   Vray, Muriel ^f   Lemée, Véronique ^c   Simon, François ^d,e   Plantier, Jean Christophe ^a,b,c  

^a NORMANDIE UNIVERSITÉ   (France)

^b UNIVERSITY OF ROUEN   (France)

^c ROUEN UNIVERSITY HOSPITAL   (France)

^d UNIVERSITÉ PARIS DESCARTES   (France)

^e SAINT LOUIS HOSPITAL   (France)

^f INSTITUT PASTEUR   (France)

Author keywords

Genetic diversity; HIV 1; HIV O; Quantification; Viral load

Indexed keywords

VIRUS RNA;

ARTICLE; FALSE NEGATIVE RESULT; HIV TEST; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP M; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP N; HUMAN IMMUNODEFICIENCY VIRUS 1 GROUP O; INTERMETHOD COMPARISON; NONHUMAN; NUCLEIC ACID SEQUENCE BASED AMPLIFICATION; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; VIRUS LOAD; COMPARATIVE STUDY; EVALUATION STUDY; GENETICS; HIV INFECTIONS; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PROCEDURES; SENSITIVITY AND SPECIFICITY; VIROLOGY;

HIV INFECTIONS; HIV-1; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; SENSITIVITY AND SPECIFICITY; VIRAL LOAD;

EID: 84941565912     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.08.007     Document Type: Article

References (22)

1. Hemelaar J., Gouws E., Ghys P.D., Osmanov S. Global trends in molecular epidemiology of HIV-1 during 2000-2007. AIDS 2011, 25:679-689.
2. Gueudin M., Plantier J.C., Lemee V., Schmitt M.P., Chartier L., Bourlet T., Ruffault A., Damond F., Vray M., Simon F. Evaluation of the Roche Cobas TaqMan and Abbott RealTime extraction-quantification systems for HIV-1 subtypes. J. Acquir. Immune Defic. Syndr. 2007, 44:500-505.
3. Wirden M., Tubiana R., Marguet F., Leroy I., Simon A., Bonmarchand M., Ait-Arkoub Z., Murphy R., Marcelin A.G., Katlama C., Calvez V. Impact of discrepancies between the Abbott realtime and cobas TaqMan assays for quantification of human immunodeficiency virus type 1 group M non-B subtypes. J. Clin. Microbiol. 2009, 47:1543-1545.
4. Damond F., Roquebert B., Benard A., Collin G., Miceli M., Yeni P., Brun-Vezinet F., Descamps D. Human immunodeficiency virus type 1 (HIV-1) plasma load discrepancies between the Roche COBAS AMPLICOR HIV-1 MONITOR Version 1. 5 and the Roche COBAS AmpliPrep/COBAS TaqMan HIV-1 assays. J. Clin. Microbiol. 2007, 45:3436-3438.
5. Bourlet T., Signori-Schmuck A., Roche L., Icard V., Saoudin H., Trabaud M.A., Tardy J.C., Morand P., Pozzetto B., Ecochard R., Andre P. HIV-1 load comparison using four commercial real-time assays. J. Clin. Microbiol. 2011, 49:292-297.
6. Delaugerre C., Denis B., Peytavin G., Palmer P., Mourez T., Le Goff J., Molina J.M., Simon F. Clinical and resistance consequences of misquantification of plasma and cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) RNA in samples from an HIV-1 subtype G-infected patient. J. Clin. Microbiol. 2009, 47:3763-3764.
7. Mourez T., Simon F., Plantier J.C. Non-M variants of human immunodeficiency virus type 1. Clin. Microbiol. Rev. 2013, 26:448-461.
8. Plantier J.C., Gueudin M., Damond F., Braun J., Mauclere P., Simon F. Plasma RNA quantification and HIV-divergent strains. J. Acquir. Immune Defic. Syndr. 2003, 33(1):1-7.
9. Sire J.M., Vray M., Merzouk M., Plantier J.C., Pavie J., Maylin S., Timsit J., Lascoux-Combe C., Molina J.M., Simon F., Delaugerre C. Comparative RNA Quantification of HIV-1 Group M and Non-M With the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 v2. 0 and Abbott real-time HIV-1 PCR Assays. J. Acquir. Immune Defic. Syndr. 2011, 56:239-243.
10. Gomes P., Carvalho A.P., Diogo I., Goncalves F., Costa I., Cabanas J., Camacho R.J. Comparison of the NucliSENS EasyQ HIV -1 v2. 0 with Abbott m2000rt RealTime HIV -1 assay for plasma RNA quantitation in different HIV -1 subtypes. J. Virol. Methods 2013.
11. Muenchhoff M., Madurai S., Hempenstall A.J., Adland E., Carlqvist A., Moonsamy A., Jaggernath M., Mlotshwa B., Siboto E., Ndung'u T., Goulder P.J. Evaluation of the NucliSens EasyQ v2. 0 assay in comparison with the Roche Amplicor v1. 5 and the Roche CAP/CTM HIV-1 Test v2. 0 in quantification of C-clade HIV-1 in plasma. PLoS One 2014, 9:e103983.
12. Xu S., Song A., Nie J., Li X., Meng S., Zhang C., Wang Y. Comparison between the automated Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test version 2.0 assay and its version 1 and Nuclisens HIV-1 EasyQ version 2.0 assays when measuring diverse HIV-1 genotypes in China. J. Clin. Virol. 2012, 53:33-37.
13. Simon F., Loussert-Ajaka I., Damond F., Saragosti S., Barin F., Brun-Vezinet F. HIV type 1 diversity in northern Paris, France. AIDS Res. Hum. Retroviruses 1996, 12:1427-1433.
14. Simon F., Souquiere S., Damond F., Kfutwah A., Makuwa M., Leroy E., Rouquet P., Berthier J.L., Rigoulet J., Lecu A., Telfer P.T., Pandrea I., Plantier J.C., Barre-Sinoussi F., Roques P., Muller-Trutwin M.C., Apetrei C. Synthetic peptide strategy for the detection of and discrimination among highly divergent primate lentiviruses. AIDS Res. Hum. Retroviruses 2001, 17:937-952.
15. Delaugerre C., Gallien S., Flandre P., Mathez D., Amarsy R., Ferret S., Timsit J., Molina J.M., de Truchis P. Impact of low-level-viremia on HIV-1 drug-resistance evolution among antiretroviral treated-patients. PLoS One 2012, 7:e36673.
16. Damond F., Avettand-Fenoel V., Collin G., Roquebert B., Plantier J.C., Ganon A., Sizmann D., Babiel R., Glaubitz J., Chaix M.L., Brun-Vezinet F., Descamps D., Rouzioux C. Evaluation of an upgraded version of the Roche Cobas AmpliPrep/Cobas TaqMan HIV-1 test for HIV-1 load quantification. J. Clin. Microbiol. 2010, 48:1413-1416.
17. Scott L.E., Noble L.D., Moloi J., Erasmus L., Venter W.D., Stevens W. Evaluation of the Abbott m2000 RealTime human immunodeficiency virus type 1 (HIV-1) assay for HIV load monitoring in South Africa compared to the Roche Cobas AmpliPrep-Cobas Amplicor, Roche Cobas AmpliPrep-Cobas TaqMan HIV-1, and BioMerieux NucliSENS EasyQ HIV-1 assays. J. Clin. Microbiol. 2009, 47:2209-2217.
18. Swanson P., de Mendoza C., Joshi Y., Golden A., Hodinka R.L., Soriano V., Devare S.G., Hackett J. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1. 5, VERSANT HIV-1 RNA 3. 0, and NucliSens HIV-1 QT. J. Clin. Microbiol. 2005, 43:3860-3868.
19. Delaugerre C., De O., liveira F., Lascoux-Combe C., Plantier J.C., Simon F. HIV-1 group N: travelling beyond Cameroon. Lancet 2011, 378:1894.
20. Tang N., Huang S., Salituro J., Mak W.B., Cloherty G., Johanson J., Li Y.H., Schneider G., Robinson J., Hackett J., Swanson P., Abravaya K. A RealTime HIV-1 viral load assay for automated quantitation of HIV-1 RNA in genetically diverse group M subtypes A-H, group O and group N samples. J. Virol. Methods 2007, 146:236-245.
21. Gueudin M., Leoz M., Lemee V., De Oliveira F., Vessiere A., Kfutwah A., Plantier J.C. A new real-time quantitative PCR for diagnosis and monitoring of HIV-1 group O infection. J. Clin. Microbiol. 2012, 50:831-836.
22. Yeni P. Prise en Charge Médicale des Personnes Infectées par le VIH 2010, La Documentation Française, (French).